4Hetler LA,Grimm C.Ackermann S.et al.An interleukin-6 gene promoter polymorphism.Influences the biological phenotype of orarian cancer[J].Cancer Res,2003,63(12):3066.
5Abdollahi T,Robertson NM,Abdollahi A,et al.Identification of interleukin8 as an inhibitor of tumor necrosis tactov-related apoptosisinducing Ligand-induced apoptosis in the ovarian carcinoma cell line OVCAR3[J].Cancer Res.2003,63 (15):4521.
二级参考文献59
1Rossi D, Zlotnik A. The biology of chemokines and their receptors.Annu Rev Immunol, 2000, 18( 1 ): 217-242.
2Balkwill F. Chemokine biology in cancer. Semin Immunol, 2003, 15(1): 49-55.
3Balkwill F.Cancer and the chemokine network. Nat Rev Cancer,2004, 4(7): 540-550.
4Homey B, Muller A, Zlotnik A. Chemokines: agents for the immunotherapy of cancer? Nat Rev Immunol, 2002, 2 (3): 175- 184.
5Ruckes T, Saul D, Van Snick J, et al. Autocrine antiapoptotic stimulation of cultured adult T- cell leukemia cells by overexpression of the chemokine I-309. Blood, 2001,98(4): 1150-1159.
6Pirtskhalaishvili G, Nelson JB. Endothelium- derived factors as paracrine mediators of prostate cancer progression. Prostate, 2000, 44(1): 77-87.
7Kawada K, Sonoshita M, Sakashita H, et al. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Res, 2004, 64(11): 4010-4017.
8Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature, 2001,410(6824): 50-56.
9Robledo MM, Bartolome RA, Longo N, et al. Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J Biol Chem, 2001,276(48): 45098-45105.
10Mori T, Doi R, Koizumi M, et al. CXCR4 antagonist inhibits stromal cell-derived factor 1- induced migration and invasion of human pancreatic cancer. Mol Cancer Ther, 2004, 3(1): 29-37.
